How and when does an anticancer drug leave its binding site?

Pratyush Tiwary1, Jagannath Mondal2, B J Berne1

  • 1Department of Chemistry, Columbia University, New York, NY 10027, USA.

Science Advances
|June 6, 2017
PubMed

Insights

Researchers simulated the anticancer drug dasatinib unbinding from c-Src kinase. Water molecules facilitate unbinding by acting as a molecular switch, explaining challenges in developing drugs with longer residence times.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Pharmacology

Background:

  • Atomistic resolution of drug unbinding from proteins is a significant experimental and computational challenge.
  • Understanding drug-protein interactions is crucial for developing effective therapeutics.

Purpose of the Study:

  • To elucidate the atomistic mechanisms of dasatinib unbinding from c-Src kinase.
  • To investigate the role of protein-water interactions in drug residence time.

Main Methods:

  • Enhanced sampling molecular dynamics simulations were employed.
  • Multiple unbinding trajectories were generated and analyzed.

Main Results:

  • Dasatinib unbinding pathways from c-Src kinase were resolved at atomistic detail.
  • Simulated residence time agreed with experimental data.
  • Coupled protein-water movements and metastable intermediates were observed.
  • Water molecules were found to form a hydrogen bond bridge, elongating a salt bridge and facilitating conformational changes essential for unbinding.

Conclusions:

  • Water insertion into the salt bridge acts as a critical molecular switch controlling dasatinib unbinding.
  • The findings provide a mechanistic explanation for difficulties in engineering drugs with prolonged residence times against specific kinase conformations.

Related Concept Videos

Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.0K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
624
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.4K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.2K